An experimental pill could slow memory loss and brain shrinkage in some Alzheimer’s patients, new research suggests. The pill, called ALZ-801 (valiltramiprosate), was shown to be effective in people ...

As an internal medicine doctor, I used to care for Alzheimer’s patients. Now, at just 60 years old, I am one. My diagnosis is not the future most people hope for — but there is finally a generation of ...

Mahmood’s interest in neuroscience led her to Indianapolis in summer 2025, where she helped with student research into early ...

Alzheimer’s isn’t just one problem—it’s a tangled mix of biology, aging, and overall health. That’s why drugs targeting a single factor have fallen short, even as new treatments show modest benefits.

Research suggests that people in two specific jobs — taxi drivers and ambulance drivers — have the lowest risk of dying from Alzheimer's Disease.

Actinogen anticipates final topline efficacy and safety results for the full 36-week treatment period in November 2026.

An earlier diagnosis and intervention strategy for Alzheimer's disease is on the horizon, signaling a need to overhaul current detection methods and patient care protocols, experts at the Alzheimer's ...

A new, stronger flu shot could slash Alzheimer’s risk in half, according to new data. The study, led by researchers at the ...

Programs that support caregivers of patients with dementia could bring substantial benefits at a fraction of the price of an Alzheimer’s drug. Disease-slowing Alzheimer’s drugs entered the market in ...

Reviewed by Anton Porsteinsson, MD, Director of the University of Rochester Alzheimer’s Disease Care, Research and Education Program (AD-CARE) in New York; and the first William B. and Sheila Konar, ...

Only 2 years after giving birth to her son, Gunnar, at age 44, Staci Marklin received a diagnosis that would change her and ...